Malignant salivary gland tumors of the tongue: A multicenter REFCOR study
Valentine Poissonnet,Emmanuelle Uro‐Coste,Emilien Chabrillac,Anouchka Modesto,Caroline Even,Nicolas Fakhry,Renaud Garrel,Olivier Malard,Florian Chatelet,Charles Dupin,Franck Jegoux,Philippe Schultz,Dorian Culié,Robin Baudouin,Diane Evrard,Pierre Ransy,Sylvain Morinière,Haitham Mirghani,François Mouawad,Christian Righini,Suzy Duflo,Jean‐Paul Marie,Florence Jourdan‐Soulier,Sarah Atallah,Esteban Brenet,Chloé Bertolus,Philippe Ceruse,Lionel Ramin,Xavier Dufour,Duc Trung Nguyen,Vianney Bastit,Bertille Segier,Sébastien Vergez
DOI: https://doi.org/10.1002/ijc.35167
2024-09-22
International Journal of Cancer
Abstract:What's new? Cancer of the salivary glands is a rare and heterogeneous group of tumors, and not much is known about what factors predict favorable or unfavorable outcomes. Here, the authors analyzed a cohort of patients diagnosed between 2009 and 2018 at 28 different cancer centers in France, a total of 103 patients, to identify prognostic factors. They found that surgery was associated with better event‐free survival and that lymph node status was the main prognostic factor for overall survival. Salivary carcinomas of minor salivary glands are very infrequent tumors. When located in the tongue, the therapeutic strategy may comprise upfront surgery, which may be debilitating, and/or (chemo‐)radiotherapy. The aim of this study was to identify the prognostic factors of salivary carcinomas of the tongue in a population‐based cohort. This retrospective multicentric study, based on the "Réseau d'Expertise Français sur les Cancers ORL Rares" (REFCOR), included all the patients with a salivary carcinoma of the tongue, diagnosed between January 2009 and December 2018. Dubious slides were reviewed by REFCOR expert pathologists to ensure diagnostic accuracy. Treatment was performed in accordance with national REFCOR recommendations. From 28 centers, 103 patients were included in this study. Median age at diagnosis was 63 years, and 60.2% were female. Tumors were adenoid cystic carcinomas (41.7%), mucoepidermoid carcinomas (30.1%), and other adenocarcinomas (28.2%). Primary treatment was surgical for 61.2% of them. Five‐year overall survival (OS) and event‐free survival (EFS) rates were 84.7% and 38.6%, respectively. In multivariable analysis, EFS was significantly worse in case of nonsurgical treatment, alcohol consumption, and glossotonsillar sulcus involvement. N‐positive status was the only significant prognostic factor for OS in multivariable analysis. Salivary carcinomas of the tongue represent a heterogeneous group of rare tumors, with a high risk of recurrence. In this national cohort, surgery was associated with better EFS and N‐status was the main independent prognostic factor for OS.
oncology